Janus Henderson Group PLC Ardelyx, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 24,977,006 shares of ARDX stock, worth $98.9 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
24,977,006
Previous 24,387,941
2.42%
Holding current value
$98.9 Million
Previous $126 Million
2.73%
% of portfolio
0.07%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding ARDX
# of Institutions
235Shares Held
166MCall Options Held
490KPut Options Held
2.35M-
Black Rock Inc. New York, NY17.6MShares$69.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$59.4 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$44.2 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X08.38MShares$33.2 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $612M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...